TY - JOUR A1 - Rabe, Eberhard A1 - Földi, Ethel A1 - Gerlach, Horst A1 - Jünger, Michael A1 - Lulay, Gerd Rudolf A1 - Miller, Anya A1 - Protz, Kerstin A1 - Reich-Schupke, Stefanie A1 - Schwarz, Thomas A1 - Stücker, Markus A1 - Valesky, Eva Maria A1 - Pannier, Felizitas T1 - Medical compression therapy of the extremities with medical compression stockings (MCS), phlebological compression bandages (PCB), and medical adaptive compression systems (MAC): S2k guideline of the German Phlebology Society (DGP) in cooperation with the following professional associations: DDG, DGA, DGG, GDL, DGL, BVP T1 - Medizinische Kompressionstherapie der Extremitäten mit Medizinischem Kompressionsstrumpf (MKS), Phlebologischem Kompressionsverband (PKV) und Medizinischen adaptiven Kompressionssystemen (MAK): S2k-Leitlinie der Deutschen Gesellschaft für Phlebologie (DGP) in Kooperation mit folgenden Fachgesellschaften: DDG, DGA, DGG, GDL, DGL, BVP T2 - Der Hautarzt N2 - The present guidelines comprise relevant aspects of the use of compression therapy with medical compression stockings (MCS), phlebological compression bandages (PCB), and medical adaptive compression systems (MAC) based on an extensive literature search based on the state of scientific knowledge as of December 2018. These guidelines were prepared by experts within the framework of an electronic consensus process and a consensus conference which took place in Bielefeld, Germany, on September 27, 2018, on the initiative of the German Society of Phlebology (DGP) and the Professional Association of Phlebologists (BVP). The guidelines were adopted by the boards and advisory councils of the DGP and the BVP, and of the participating professional associations, after preparation by the group of experts and extensive debate, on December 31, 2018. These guidelines do not cover compression therapy with medical thrombosis prophylaxis stockings (MTPS) or with intermittent pneumatic compression (IPC), which are treated in other guidelines (AWMF 003-001, S3; AWMF 037-001, S1). The recommendations of the AWMF guidelines “Diagnostics and Treatment of Lymphedema” (registration number 058-001) and “Lipedema” (registration number 037-012) shall also be taken into account where appropriate: https://www.awmf.org/uploads/tx_szleitlinien/058-001l_S2k_Diagnostik_und_Therapie_der_Lymphoedeme_2017-05.pdf, https://www.awmf.org/uploads/tx_szleitlinien/037-012l_S1_Lipoedem_2016-01.pdf. Y1 - 2021 UR - http://publikationen.ub.uni-frankfurt.de/frontdoor/index/index/docId/69768 UR - https://nbn-resolving.org/urn:nbn:de:hebis:30:3-697689 SN - 1432-1173 N1 - Additional information This S2k guideline was published online by the AWMF in early 2019 (registration number 037/005) and is valid until 30.12.2023. VL - 72 IS - 2 SP - 37 EP - 50 PB - Springer CY - Berlin ; Heidelberg ; New York ER -